About NEP INTERLONG Company

Enterprise mission Adhering to the concept of “health makes the future”, Neptune Interlon uses modern biotechnology and pharmaceutical formulation technology as an innovative platform to develop cytokine protein therapeutics and preventive biological products, create core competitiveness represented by independent intellectual property product development and specialized marketing capabilities, gradually establish a leading position in the domestic market, and at the same time launch an international strategy. Huge market potential triggers unlimited business opportunities In the past, China's level of investment in medical expenses or disease prevention was far lower than that of developed countries. However, booming economic development has improved people's lives, so the focus on health is higher than before. Coupled with the aging population, domestic demand for medicines has increased dramatically. Furthermore, China's biotechnology is at a similar level to international technology, and has a good momentum of development, and the prospects are very optimistic. The company believes that China's biopharmaceutical industry will become more mature, bringing unlimited business opportunities to the company. Grasp technological trends, excellent R&D capabilities Neptune Interlon has strong scientific research capabilities, and the R&D team has professional knowledge and rich R&D experience. The company has independent research and development capabilities. The R&D pilot plant meets GMP standards, and all laboratories are equipped with advanced research facilities and test instruments. The company has also cooperated with many strong professional biotechnology companies or research institutes, and achieved good results. The biotechnological drugs developed and produced by the company have the advantages of low cost, high efficiency, safety and reliability, and have great potential for development. Furthermore, with regard to the core technology of the new product, the company has obtained 1 core technology invention patent, and is currently applying for invention patents for a number of technologies. In the next three years, the company will launch several new products with independent intellectual property rights, and the market prospects are broad. Enjoy brand advantages without fear of market competition The products of Neptune Interlon use the licensed trademark “Haiwang” of Neptune Pharmaceuticals, which is a well-known trademark in China. The brand has established an outstanding reputation and popularity in China over the years. Brand advantage helps increase the market's acceptance of various new drugs launched by the company in the future, and greatly enhances the company's competitiveness. Excellent corporate professionals strictly control quality The company's management has a professional background and rich corporate experience. They have an in-depth understanding of the development of the industry, look forward to the company's future direction and strategy, and also pay attention to employee training and actively recruit industry experts. The company knows that the quality of products is as important as scientific research, and strictly controls quality, so the products have a good reputation in China. The company's current production follows GMP standards and operating guidelines, and strictly implements product monitoring. Look forward to the future and achieve the future With strong R&D capabilities, professional marketing methods, strict quality control and excellent enterprise management, Neptune Interlon has accumulated rich management experience in China, established a certain level of popularity, and successfully sought considerable market coverage. The company will continue to expand production scale and enhance R&D capabilities, combine advanced technology, increase product variety, and actively expand business to overseas markets to achieve future human health.